Sevillano Angel M, Gutierrez Eduardo, Morales Enrique, Hernandez Eduardo, Molina Maria, Gonzalez Ester, Praga Manuel
Department of Nephrology , 12 de Octubre University Hospital , Madrid , Spain.
Department of Nephrology , 12 de Octubre University Hospital , Madrid , Spain ; Department of Medicine , Complutense University , Madrid , Spain.
Clin Kidney J. 2014 Jun;7(3):251-6. doi: 10.1093/ckj/sfu033. Epub 2014 Apr 15.
Some patients with thin basement membrane disease (TBMD) develop proteinuria, hypertension and different degrees of CKD, besides the persistent microhaematuria characteristic of the disease. Little is known about factors associated with this unfavourable outcome.
We reviewed clinical, pathological and radiological features of 32 patients with biopsy-proven TBMD. Patients were divided in two groups: those with persistent normal kidney function and negative or minimal proteinuria (n = 16) and those with persistent proteinuria >0.5 g/day (n = 16).
Patients with proteinuria had a worse kidney function at baseline than those with negative proteinuria. Global or segmental glomerulosclerosis, together with interstitial fibrosis, was found in 37% of patients with proteinuria. All proteinuric patients were treated with renin-angiotensin system blockers. At the end of follow-up (198 months in proteinuric patients and 210 months in patients with negative proteinuria) the prevalence of hypertension was 68% in proteinuric patients (12% at baseline), compared with 12 and 6%, respectively, in non-proteinuric patients. A slow decline of renal function was observed in proteinuric patients, although no patient developed end-stage kidney disease. Ultrasound studies showed bilateral kidney cysts in nine patients (56%) with proteinuria. Cysts were bilateral and countless in six patients, and bilateral but with a limited number of cysts in the three remaining patients. No cysts were found in patients with negative proteinuria.
Some patients with TBMD develop hypertension, proteinuria and CKD. Multiple bilateral kidney cysts were found in a majority (56%) of these patients. Further studies are needed to investigate the pathogenesis and the influence on long-term outcome of this TBMD-associated multiple kidney cysts.
一些薄基底膜肾病(TBMD)患者除了具有该疾病特有的持续性镜下血尿外,还会出现蛋白尿、高血压和不同程度的慢性肾脏病(CKD)。关于与这种不良结局相关的因素知之甚少。
我们回顾了32例经活检证实为TBMD患者的临床、病理和放射学特征。患者分为两组:肾功能持续正常且蛋白尿阴性或微量的患者(n = 16)和蛋白尿持续>0.5 g/天的患者(n = 16)。
蛋白尿患者基线时的肾功能比蛋白尿阴性患者更差。37%的蛋白尿患者存在全球或节段性肾小球硬化以及间质纤维化。所有蛋白尿患者均接受肾素 - 血管紧张素系统阻滞剂治疗。随访结束时(蛋白尿患者为198个月,蛋白尿阴性患者为210个月),蛋白尿患者的高血压患病率为68%(基线时为12%),而非蛋白尿患者分别为12%和6%。虽然没有患者发展为终末期肾病,但在蛋白尿患者中观察到肾功能缓慢下降。超声检查显示9例(56%)蛋白尿患者有双侧肾囊肿。6例患者的囊肿为双侧且数量众多,其余3例患者的囊肿为双侧但数量有限。蛋白尿阴性患者未发现囊肿。
一些TBMD患者会出现高血压、蛋白尿和CKD。在这些患者中的大多数(56%)发现了多发性双侧肾囊肿。需要进一步研究来探讨这种与TBMD相关的多发性肾囊肿的发病机制及其对长期结局的影响。